Thomas Lai is a graduate of the University of California; Los Angeles where he majored in Molecular, Cell, and Developmental Biology. As an undergraduate research student in the Robert Prins Lab at UCLA, Thomas studied epigenetic control of cancer-testis antigens to optimize treatment of glioblastoma with immunotherapy. Thomas is currently a lab assistant with the Prins lab while he applies to Medical Scientist Training Programs.